Oxidative Stress, Gut Microbiota, and Extracellular Vesicles: Interconnected Pathways and Therapeutic Potentials
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3148 - 3148
Published: March 28, 2025
Oxidative
stress
(OS)
and
gut
microbiota
are
crucial
factors
influencing
human
health,
each
playing
a
significant
role
in
the
development
progression
of
chronic
diseases.
This
review
provides
comprehensive
analysis
complex
interplay
between
these
two
factors,
focusing
on
how
an
imbalance
reactive
oxygen
species
(ROS)
antioxidants
leads
to
OS,
disrupting
cellular
homeostasis
contributing
range
conditions,
including
metabolic
disorders,
cardiovascular
diseases,
neurological
cancer.
The
microbiota,
diverse
community
microorganisms
residing
gastrointestinal
tract,
is
essential
for
regulating
immune
responses,
pathways,
overall
health.
Dysbiosis,
composition,
closely
associated
with
inflammation,
dysfunction,
various
highlights
influences
influenced
by
complicating
pathophysiology
many
conditions.
Furthermore,
emerging
evidence
has
identified
extracellular
vesicles
(EVs)
as
critical
facilitators
crosstalk
OS
microbiota.
EVs
also
play
signaling
host
tissues,
modulating
processes.
function
holds
promise
targeted
therapies
aimed
at
restoring
microbial
balance
mitigating
OS.
Personalized
therapeutic
approaches,
probiotics,
antioxidants,
fecal
transplantation-based
strategies,
can
be
used
address
OS-related
diseases
improve
health
outcomes.
Nonetheless,
further
research
needed
study
molecular
mechanisms
underlying
interactions
potential
innovative
interventions
offer
novel
strategies
managing
enhancing
Language: Английский
Redox status of biomarkers in serum of dogs with hypothyroidism and its treatment with levothyroxine sodium
Ling Zhu,
No information about this author
Jinge Han,
No information about this author
Halihaxi Bahetijiang
No information about this author
et al.
Frontiers in Veterinary Science,
Journal Year:
2025,
Volume and Issue:
12
Published: April 4, 2025
Information
regarding
canine
hypothyroidism
in
China
remains
limited,
particularly
the
redox
status
of
affected
dogs.
Therefore,
objective
this
study
was
to
evaluate
dogs
with
and
observe
how
it
changed
after
levothyroxine
replacement
therapy.
A
total
10
healthy
(control
group)
(treatment
from
Agricultural
University
Veterinary
Teaching
Hospital
were
included
study.
The
assessed
all
20
Thyroid
profiles
such
as
thyroxine
(T4),
free
(fT4),
thyroid-stimulating
hormone
(TSH)
biomarkers
oxidative
stress,
including
superoxide
dismutase
(SOD),
catalase
(CAT),
glutathione
peroxidase
(GSH-px),
malondialdehyde
(MDA),
on
day
0
days
14
45
post-levothyroxine
sodium
treatment
hypothyroidism.
Dogs
had
decreased
levels
serum
T4
fT4
increased
TSH.
Based
SOD,
CAT,
GSH-px,
MDA,
stress.
Following
45-day
(0.02
mg/kg
orally
twice
daily),
antioxidant
parameters
improved
progressively:
SOD
60.2
76.7
U/mL
(Day
0-14)
further
83.3
45);
CAT
105.9
115.5
mU/mL
reaching
132.9
GSH-Px
10.2
8.4
then
9.7
45),
while
MDA
8.2→6.8→4.4
μmol/L
correspondingly.
In
conclusion,
TSH
concentrations,
addition
concentrations
activities,
indicated
that
there
stress
However,
significant
improvements
daily)
for
days.
Language: Английский